Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Five analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $21.00.
Several research firms recently commented on SBRA. Wells Fargo & Company raised their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Jefferies Financial Group reissued a “buy” rating and set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Monday, December 15th. National Bankshares set a $22.00 price objective on shares of Sabra Healthcare REIT in a research note on Friday, October 17th. Finally, UBS Group started coverage on shares of Sabra Healthcare REIT in a report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price objective for the company.
Institutional Trading of Sabra Healthcare REIT
Sabra Healthcare REIT Price Performance
NASDAQ:SBRA opened at $18.79 on Wednesday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 5.19 and a current ratio of 5.19. The company has a 50-day moving average of $18.69 and a 200-day moving average of $18.58. Sabra Healthcare REIT has a 52 week low of $15.60 and a 52 week high of $19.97. The company has a market capitalization of $4.69 billion, a price-to-earnings ratio of 26.10, a PEG ratio of 1.20 and a beta of 0.67.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last posted its earnings results on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. The business had revenue of $190.04 million for the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a net margin of 23.50% and a return on equity of 6.38%. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, equities research analysts anticipate that Sabra Healthcare REIT will post 1.45 earnings per share for the current fiscal year.
Sabra Healthcare REIT Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Monday, November 17th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 6.4%. The ex-dividend date of this dividend was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 166.67%.
Sabra Healthcare REIT Company Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Read More
- Five stocks we like better than Sabra Healthcare REIT
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
